Morphologic and Metabolic Comparison of Treatment Responsiveness with (18)Fludeoxyglucose-Positron Emission Tomography/Computed Tomography According to Lung Cancer Type

Creative Commons License

Borksuz M. F., Erselcan T., HASBEK Z., YÜCEL B., TURGUT B.

MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.25, sa.2, ss.63-69, 2016 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/mirt.36349
  • Dergi Adı: MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.63-69
  • Sivas Cumhuriyet Üniversitesi Adresli: Evet

Özet

Objective: The aim of the present study was to evaluate the response to treatment by histopathologic type in patients with lung cancer and under follow-up with F-18-fluoro-2deoxy-glucose-positron emission tomography/computed tomography (F-18-FDG PET/CT) imaging by using Response Evaluation Criteria in Solid Tumors (RECIST) and European Organisation for Research and Treatment of Cancer (EORTC) criteria that evaluate morphologic and metabolic parameters.